CARCINOMA, PANCREATIC DUCTAL
Clinical trials for CARCINOMA, PANCREATIC DUCTAL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, PANCREATIC DUCTAL trials appear
Sign up with your email to follow new studies for CARCINOMA, PANCREATIC DUCTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets KRAS-driven cancers in early trial
Disease control Recruiting nowThis study tests a new experimental drug (PF-07934040) in people with advanced solid tumors that have a KRAS gene mutation, including certain lung, colon, and pancreatic cancers. The drug is taken as a pill twice a day, either alone or with other anti-cancer medicines given by IV…
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
New hope for pancreatic cancer? trial combines experimental drug with chemo
Disease control Recruiting nowThis study tests whether adding an experimental drug called relacorilant to standard chemotherapy (nab-paclitaxel and gemcitabine) can help people with metastatic pancreatic cancer live longer without their disease getting worse. About 60 adults who have not yet been treated for …
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Genetic test may guide better chemo for pancreatic cancer patients
Knowledge-focused Recruiting nowThis study tests whether using genetic signatures from a liver biopsy can help doctors choose the best first chemotherapy for people with advanced pancreatic cancer. About 85 participants will have their treatment selected based on these genetic markers. The goal is to see if thi…
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC